Milestone Pharmaceuticals Inc. (NASDAQ: MIST)
$1.63
-0.0200 ( -1.21% ) 168.0K
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Market Data
Open
$1.63
Previous close
$1.65
Volume
168.0K
Market cap
$85.22M
Day range
$1.60 - $1.70
52 week range
$1.12 - $3.62
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Jul 15, 2024 |
8-k | 8K-related | 16 | Jul 15, 2024 |
def | Proxies and info statements | 14 | Jul 15, 2024 |
8-k | 8K-related | 15 | May 29, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
10-q | Quarterly Reports | 59 | May 13, 2024 |
10-k/a | Quarterly Reports | 15 | Apr 29, 2024 |
8-k | 8K-related | 15 | Apr 08, 2024 |
8-k | 8K-related | 15 | Mar 28, 2024 |
10-k | Annual reports | 111 | Mar 21, 2024 |